![Gennova Biopharmaceuticals gets DCGI nod for mRNA-based Covid booster vaccine](https://images.assettype.com/fortuneindia%2F2023-06%2F9a167358-feed-49b6-b239-16d1e598fb8d%2FVaccine__3_.jpg?w=300&q=95)
Gennova Biopharmaceuticals gets DCGI nod for mRNA-based Covid booster vaccine
GEMCOVAC-OM is the first booster Covid-19 vaccine developed in India against the highly transmissible Omicron variant.
GEMCOVAC-OM is the first booster Covid-19 vaccine developed in India against the highly transmissible Omicron variant.
Gennova's vaccine will be available for adults above 18 years of age. It will be a two-dose vaccine that will be administered intramuscularly at 28 days apart